skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

11 Total results for product and free and sample content found

Generics Bulletin

EU Reforms Must Heed Pandemic Lessons

By David Wallace 08 Dec 2020

Covid19 Eu reforms

Reforms set out by the European Commission to better prepare the EU for future health crises must heed key lessons learned from experiences of the COVID-19 pandemic, such as the benefits of digitalization, Medicines for Europe has urged

Topic Coronavirus EU Policy & Regulation

Generics Bulletin

EU Reforms Must Heed Pandemic Lessons

By David Wallace 29 Nov 2020

Covid19 Eu reforms

Reforms set out by the European Commission to better prepare the EU for future health crises must heed key lessons learned from experiences of the COVID-19 pandemic, such as the benefits of digitalization, Medicines for Europe has urged.

Topic Coronavirus EU Policy & Regulation

Medtech Insight

Brexit: Medical Supplies Facing ‘Significant Disruption’ At Ports

By Ian Schofield 27 Nov 2020

Brexit: Medical Supplies Facing ‘Significant Disruption’ At Ports

As negotiators struggle to reach agreement on the future UK/EU relationship following Brexit, suppliers have been warned to expect major hold-ups next year for medical products crossing the English Channel.

Topic EU Brexit

Pink Sheet

NICE Reform Plans Aim To Help Make Post-Brexit UK A 'First Launch' Country

By Ian Schofield 17 Nov 2020

Post brexit NICE reform plans

Following a Brexit-induced delay over the summer, England's HTA body NICE has come up with a concrete set of proposals that it says will help it “robustly and efficiently” evaluate innovative technologies such as advanced therapies, histology-independent cancer treatments, and technologies for rare diseases. Industry bodies have welcomed the plans, which have just been put out for consultation.

Topic Brexit EU

Pink Sheet

England's HTA Body To Revamp Product Selection Processes

By Ian Schofield 29 Oct 2020

UK HTA Boost Revamp Product Selection Processes

Proposals from NICE now under consultation are intended to boost the health technology assessment body’s efficiency, improve transparency and governance, and raise the quality of its guidance

Topic Regulation EU

Pink Sheet

EU Pharma Strategy To Balance Innovation Incentives and Competition

By Ian Schofield 09 Oct 2020

Pharma Strategy Brainstorming

Delegates at this week’s TOPRA conference heard the European Commission’s “holistic” vision of what it would like to achieve through its pharmaceutical strategy, including incentives for innovation, security of the supply chain, product shortages, real world evidence and big data, and the availability and affordability of medicines.

Topic EU Artificial Intelligence Regulation

Pink Sheet

Germany Sets Direction Of Travel With New Biosimilar Guidelines

By Francesca Bruce 21 Sep 2020

Biosimilars Germany

Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in move towards increasing biosimilar uptake.

Topic EU Biosimilars

Medtech Insight

UK Readies Medtech And Pharma Sectors For Regulatory Life Outside The EU

By Ashley Yeo 26 Aug 2020

UK Readies Medtech And Pharma Sectors For Regulatory Life Outside The EU

Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.

Topic EU Medtech-Brexit Regulation Brexit

Pink Sheet

EU 2019 Approvals: Novel Therapies Make Strong Showing

By Ian Schofield 15 Jan 2020

EU_2019_Approvals_Novel_Therapies

Bluebird bio’s gene therapy Zynteglo, Akcea’s antisense drug Waylivra and BioMarin’s enzyme substitution therapy Palynziq were among the novel innovative medicines that were approved in Europe in 2019. 

Topic Drug Approval Standards EU Regulation

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: